KROS
Keros Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.32
+1.89%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.92x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- 2.86x
Liquidity & coverage
- Current ratio
- 21.96x
- Quick ratio
- 21.96x
- Cash ratio
- 21.20x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $254.7M
Cash & dividend
- FCF / debt
- -3.08x
- Cash flow / debt
- -3.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026